Abstract:Background: Real-time tumor tracking is one motion management method to address motion-induced uncertainty. To date, fiducial markers are often required to reliably track lung tumors with X-ray imaging, which carries risks of complications and leads to prolonged treatment time. A markerless tracking approach is thus desirable. Deep learning-based approaches have shown promise for markerless tracking, but systematic evaluation and procedures to investigate applicability in individual cases are missing. Moreover, few efforts have been made to provide bounding box prediction and mask segmentation simultaneously, which could allow either rigid or deformable multi-leaf collimator tracking. Purpose: The purpose of this study was to implement a deep learning-based markerless lung tumor tracking model exploiting patient-specific training which outputs both a bounding box and a mask segmentation simultaneously. We also aimed to compare the two kinds of predictions and to implement a specific procedure to understand the feasibility of markerless tracking on individual cases. Methods: We first trained a Retina U-Net baseline model on digitally reconstructed radiographs (DRRs) generated from a public dataset containing 875 CT scans and corresponding lung nodule annotations. Afterwards, we used an independent cohort of 97 lung patients to develop a patient-specific refinement procedure. In order to determine the optimal hyperparameters for automatic patient-specific training, we selected 13 patients for validation where the baseline model predicted a bounding box on planning CT (PCT)-DRR with intersection over union (IoU) with the ground-truth higher than 0.7. The final test set contained the remaining 84 patients with varying PCT-DRR IoU. For each testing patient, the baseline model was refined on the PCT-DRR to generate a patient-specific model, which was then tested on a separate 10-phase 4DCT-DRR to mimic the intrafraction motion during treatment. A template matching algorithm served as benchmark model. The testing results were evaluated by four metrics: the center of mass (COM) error and the Dice similarity coefficient (DSC) for segmentation masks, and the center of box (COB) error and the DSC for bounding box detections. Performance was compared to the benchmark model including statistical testing for significance. Results: A PCT-DRR IoU value of 0.2 was shown to be the threshold dividing inconsistent (68%) and consistent (100%) success (defined as mean bounding box DSC > 0.6) of PS models on 4DCT-DRRs. Thirty-seven out of the eighty-four testing cases had a PCT-DRR IoU above 0.2. For these 37 cases, the mean COM error was 2.6 mm, the mean segmentation DSC was 0.78, the mean COB error was 2.7 mm, and the mean box DSC was 0.83. Including the validation cases, the model was applicable to 50 out of 97 patients when using the PCT-DRR IoU threshold of 0.2. The inference time per frame was 170 ms. The model outperformed the benchmark model on all metrics, and the comparison was significant (p < 0.001) over the 37 PCT-DRR IoU > 0.2 cases, but not over the undifferentiated 84 testing cases. Conclusions: The implemented patient-specific refinement approach based on a pre-trained baseline model was shown to be applicable to markerless tumor tracking in simulated radiographs for lung cases.

Optimal Surface Marker Locations for Tumor Motion Estimation in Lung Cancer Radiotherapy

TH‐C‐BRC‐07: Automated Identification of Surface Marker Positions to Maximize Tumor Tracking Accuracy

Automated Clinical Target Volume Delineation Using Deep 3D Neural Networks in Radiation Therapy of Non-small Cell Lung Cancer

A Novel Marker-Less Tumor Tracking Strategyonlow-Rank Fluoroscopic Images for Image-Guided Lung Cancer Radiotherapy

A Novel Marker-Less Lung Tumor Localization Strategy on Low-Rank Fluoroscopic Images with Similarity Learning

Markerless tracking of tumor and tissues: A motion model approach

A novel approach for estimating lung tumor motion based on dynamic features in 4D-CT

A model that predicts a Real-Time tumour surface using Intra-Treatment skin surface and end-of-Expiration and end-of-Inhalation planning CT images

MA13.01 Markerless Tumor Tracking During Lung Radiotherapy Using Intrafraction X-Ray Imaging

Respiratory Motion Estimation of Tumor Using Point Clouds of Skin Surface

Markerless Lung Tumor Localization From Intraoperative Stereo Color Fluoroscopic Images for Radiotherapy

Deep-learning-based Markerless Tumor Localization Using 2D KV/MV Image.

Fluoroscopic Tumor Tracking for Image-Guided Lung Cancer Radiotherapy.

A Super-Learner Model for Tumor Motion Prediction and Management in Radiation Therapy: Development and Feasibility Evaluation.

TU-C-214-03: Markerless Tumor Tracking Via Clustering on Low-Rank Fluoroscopic Images for Image-Guided Lung Cancer Radiotherapy

WE-AB-303-08: Direct Lung Tumor Tracking Using Short Imaging Arcs

3D tumor localization through real-time volumetric x-ray imaging for lung cancer radiotherapy

Mask R-CNN-based Tumor Localization and Segmentation in 4D Lung CT

Simultaneous object detection and segmentation for patient-specific markerless lung tumor tracking in simulated radiographs with deep learning

2D/4d Marker-Free Tumor Tracking Using 4d Cbct As the Reference Image

Robust localization of poorly visible tumor in fiducial free stereotactic body radiation therapy